BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 3021987)

  • 1. Persistence of vesicular stomatitis virus in cloned interleukin-2-dependent natural killer cell lines.
    Rosenthal KL; Zinkernagel RM; Hengartner H; Groscurth P; Dennert G; Takayesu D; Prevec L
    J Virol; 1986 Nov; 60(2):539-47. PubMed ID: 3021987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of vesicular stomatitis virus in athymic nude mice: mutations associated with natural killer cell selection.
    Vandepol SB; Holland JJ
    J Gen Virol; 1986 Mar; 67 ( Pt 3)():441-51. PubMed ID: 3005478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells.
    Puddington L; Bevan MJ; Rose JK; Lefrançois L
    J Virol; 1986 Nov; 60(2):708-17. PubMed ID: 3022003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of de novo protein synthesis in target cells recognized by cytotoxic T lymphocytes specific for vesicular stomatitis virus.
    Roscoe DM; Ishikawa K; Lyles DS
    J Virol; 1991 Dec; 65(12):6856-61. PubMed ID: 1658379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
    Browning MJ; Huang AS; Reiss CS
    J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR; Mackett M; Lefrancois L; Lyles DS; Moss B
    J Exp Med; 1986 Jun; 163(6):1529-38. PubMed ID: 3011949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysis by natural killer cells requires viral replication and glycoprotein expression.
    Schattner A; Rager-Zisman B
    Immunol Lett; 1986 Oct; 13(5):261-8. PubMed ID: 3021619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible mechanisms by which the H-2Kbm3 mutation may decrease cytotoxic T-lymphocyte recognition of vesicular stomatitis virus nucleoprotein antigen.
    Bowman MR; Lyles DS; Parce JW
    J Virol; 1987 Jun; 61(6):1992-8. PubMed ID: 3033326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesicular stomatitis virus mRNA and inhibition of translation of cellular mRNA--is there a P function in vesicular stomatitis virus?
    Lodish HF; Porter M
    J Virol; 1981 May; 38(2):504-17. PubMed ID: 6264124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The soluble viral glycoprotein of vesicular stomatitis virus efficiently sensitizes target cells for lysis by CD4+ T lymphocytes.
    Browning M; Reiss CS; Huang AS
    J Virol; 1990 Aug; 64(8):3810-6. PubMed ID: 2164598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of monensin on the synthesis, maturation and secretion of vesicular stomatitis virus proteins in a monensin-resistant Chinese hamster ovary cell line.
    Ono M; Mannen K; Shimada T; Kuwano M; Mifune K
    Cell Struct Funct; 1985 Sep; 10(3):279-94. PubMed ID: 2994891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumorigenicity of persistently infected tumors in nude mice is a function of both virus and host cell type.
    VandePol SB; Holland JJ
    J Virol; 1986 Jun; 58(3):914-20. PubMed ID: 3009896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of in vitro cytotoxic T cell clones directed against vesicular stomatitis virus.
    Rosenthal KL; Oldstone MB; Hengartner H; Zinkernagel RM
    J Immunol; 1983 Jul; 131(1):475-8. PubMed ID: 6190924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. the influence of the host cell on the inhibition of virus protein synthesis in cells double infected with vesicular stomatitis virus and mengovirus.
    Otto MJ; Lucas-Lenard J
    J Gen Virol; 1980 Oct; 50(2):293-307. PubMed ID: 6257824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies of the RNA synthesis phenotype selected during persistent infection with vesicular stomatitis virus.
    Frey TK; Youngner JS
    Virology; 1984 Jul; 136(1):211-20. PubMed ID: 6204450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-presenting B cells: efficient uptake and presentation by activated B cells for induction of cytotoxic T lymphocytes against vesicular stomatitis virus.
    Ciavarra RP; Burgess DH
    Cell Immunol; 1988 Jun; 114(1):27-40. PubMed ID: 2836071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T helper cells in cytotoxic T lymphocyte development: role of L3T4(+)-dependent and -independent T helper cell pathways in virus-specific and alloreactive cytotoxic T lymphocyte responses.
    Ciavarra RP
    Cell Immunol; 1990 Feb; 125(2):363-79. PubMed ID: 2153464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vesicular stomatitis virus-infected cells fuse when the intracellular pool of functional M protein is reduced in the presence of G protein.
    Storey DG; Kang CY
    J Virol; 1985 Feb; 53(2):374-83. PubMed ID: 2982025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell recognition of target cells expressing different antigens of vesicular stomatitis virus.
    Moller JR; Rager-Zisman B; Quan PC; Schattner A; Panush D; Rose JK; Bloom BR
    Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2456-9. PubMed ID: 2986117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nucleocapsid protein of vesicular stomatitis virus isolated from the brains of nude mice is responsible for abated viral RNA synthesis at the normal body temperature of mice.
    Doll SC; Johnson TC
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():29-36. PubMed ID: 2154537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.